192 related articles for article (PubMed ID: 8872521)
1. "Mass-forming" pancreatitis masquerades as pancreatic carcinoma.
Yamaguchi K; Chijiiwa K; Saiki S; Nakatsuka A; Tanaka M
Int J Pancreatol; 1996 Aug; 20(1):27-35. PubMed ID: 8872521
[TBL] [Abstract][Full Text] [Related]
2. Clinical analysis of inflammatory masses of the pancreatic head region.
Yeh CH; Chen HM; Jan YY; Hwang TL; Jeng LB; Chen MF
Hepatogastroenterology; 1998; 45(24):2392-8. PubMed ID: 9951930
[TBL] [Abstract][Full Text] [Related]
3. [The use of the carbohydrate antigen CA-19-9, the carcinoembryonic antigen and alpha fetoprotein in the diagnosis of pancreatic cancer].
Skvortsov SV; Kalinin AV; Lytsar' BN
Vestn Ross Akad Med Nauk; 1993; (4):47-9. PubMed ID: 7687486
[TBL] [Abstract][Full Text] [Related]
4. [Value of plasma testosterone, carcinoembryonic antigen and CA 19-9 in the differential diagnosis of pancreatic carcinoma and chronic pancreatitis].
Jurkowska G; Kulpa J; Skrodzka D; Rogowski F
Pol Arch Med Wewn; 1992 Nov; 88(5):302-9. PubMed ID: 1300550
[TBL] [Abstract][Full Text] [Related]
5. Focal chronic pancreatitis mimicking pancreatic head carcinoma: are there suggestive features on ultrasound?
Patlas M; Deitel W; Taylor B; Gallinger S; Wilson SR
Can Assoc Radiol J; 2007 Feb; 58(1):15-21. PubMed ID: 17408158
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of serum pancreatic enzymes, carbohydrate antigen 19-9, and carcinoembryonic antigen in various pancreatic diseases.
Satake K; Kanazawa G; Kho I; Chung Y; Umeyama K
Am J Gastroenterol; 1985 Aug; 80(8):630-6. PubMed ID: 2411125
[TBL] [Abstract][Full Text] [Related]
7. Is there any clinical or radiologic feature as a preoperative marker for differentiating mass-forming pancreatitis from early-stage pancreatic adenocarcinoma?
Lee H; Lee JK; Kang SS; Choi D; Jang KT; Kim JH; Lee KT; Paik SW; Yoo BC; Rhee JC
Hepatogastroenterology; 2007; 54(79):2134-40. PubMed ID: 18251176
[TBL] [Abstract][Full Text] [Related]
8. Groove pancreatitis masquerading as pancreatic carcinoma.
Yamaguchi K; Tanaka M
Am J Surg; 1992 Mar; 163(3):312-6; discussion 317-8. PubMed ID: 1539765
[TBL] [Abstract][Full Text] [Related]
9. Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer.
Ozkan H; Kaya M; Cengiz A
Hepatogastroenterology; 2003; 50(53):1669-74. PubMed ID: 14571813
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic cancer versus chronic pancreatitis: diagnosis with CA 19-9 assessment, US, CT, and CT-guided fine-needle biopsy.
DelMaschio A; Vanzulli A; Sironi S; Castrucci M; Mellone R; Staudacher C; Carlucci M; Zerbi A; Parolini D; Faravelli A
Radiology; 1991 Jan; 178(1):95-9. PubMed ID: 1984331
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune pancreatitis: differentiation from pancreatic carcinoma and normal pancreas on the basis of enhancement characteristics at dual-phase CT.
Takahashi N; Fletcher JG; Hough DM; Fidler JL; Kawashima A; Mandrekar JN; Chari ST
AJR Am J Roentgenol; 2009 Aug; 193(2):479-84. PubMed ID: 19620446
[TBL] [Abstract][Full Text] [Related]
12. Differentiation between non-hypervascular pancreatic neuroendocrine tumors and mass-forming pancreatitis using contrast-enhanced computed tomography.
Wang Y; Chen X; Wang J; Cui W; Wang C; Chen X; Wang Z
Acta Radiol; 2021 Feb; 62(2):190-197. PubMed ID: 32375515
[TBL] [Abstract][Full Text] [Related]
13. Clinical and imaging features of autoimmune pancreatitis with focal pancreatic swelling or mass formation: comparison with so-called tumor-forming pancreatitis and pancreatic carcinoma.
Wakabayashi T; Kawaura Y; Satomura Y; Watanabe H; Motoo Y; Okai T; Sawabu N
Am J Gastroenterol; 2003 Dec; 98(12):2679-87. PubMed ID: 14687817
[TBL] [Abstract][Full Text] [Related]
14. Serum CA 242 in pancreatic cancer. Comparison with CA 19-9 and CEA.
Pezzilli R; Billi P; Plate L; Laudadio MA; Sprovieri G
Ital J Gastroenterol; 1995; 27(6):296-9. PubMed ID: 8562994
[TBL] [Abstract][Full Text] [Related]
15. Non-operative differentiation between pancreatic cancer and chronic pancreatitis.
Mackie CR; Cooper MJ; Lewis MH; Moossa AR
Ann Surg; 1979 Apr; 189(4):480-7. PubMed ID: 443902
[TBL] [Abstract][Full Text] [Related]
16. Management of pancreatic mass accompanying chronic pancreatitis.
Yoshioka M; Shibata S; Sato T; Furuya T; Asanuma Y; Hashimoto M; Koyama K
J Hepatobiliary Pancreat Surg; 2002; 9(3):376-8. PubMed ID: 12353150
[TBL] [Abstract][Full Text] [Related]
17. [Computed tomography and echography in chronic pancreatitis and pancreatic carcinoma].
Brailski Kh; Petkov D; Mendizova A; Glavnicheva I; Mitova R
Vutr Boles; 1984; 23(6):17-21. PubMed ID: 6397913
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic diffusion-weighted imaging (DWI): comparison between mass-forming focal pancreatitis (FP), pancreatic cancer (PC), and normal pancreas.
Fattahi R; Balci NC; Perman WH; Hsueh EC; Alkaade S; Havlioglu N; Burton FR
J Magn Reson Imaging; 2009 Feb; 29(2):350-6. PubMed ID: 19161187
[TBL] [Abstract][Full Text] [Related]
19. CA 19-9 assay in differential diagnosis of pancreatic carcinoma from inflammatory pancreatic diseases.
Piantino P; Andriulli A; Gindro T; Pecchio F; Masoero G; Cavallini G; Naccarato R; Dobrilla G
Am J Gastroenterol; 1986 Jun; 81(6):436-9. PubMed ID: 3458359
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of diffusion-weighted magnetic resonance imaging of the pancreas: usefulness in characterizing solid pancreatic masses.
Lee SS; Byun JH; Park BJ; Park SH; Kim N; Park B; Kim JK; Lee MG
J Magn Reson Imaging; 2008 Oct; 28(4):928-36. PubMed ID: 18821618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
